MAPT and Alzheimer disease: The rapid reversal of the deficit by the two anti-MTBR/R’ antibodies using 15-min i.c.v. treatment, 3 weeks after AD1 extract exposure, indicates the prolonged presence of readily accessible synaptotoxic AD tau.